Endpoints News 生物医药· Ayisha Sharma·· 2026-10-16AI 评分21
Estuary Biotherapeutics 携 1.03 亿美元启动肾脏疾病基因疗法开发
Estuary debuts with $103M to develop kidney disease gene therapies
AI 导读
Estuary Biotherapeutics 周五携 1.03 亿美元资金亮相,用于推进两个临床前基因疗法候选药物,以开发肾脏疾病基因疗法。
正文
Estuary Biotherapeutics raised the curtain on Friday with $103 million to support the advancement of two preclinical gene therapy candidates for the most common type …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news